- In 2009, Pegasus Pharmaceuticals Group Inc. (“Pegasus”) was ranked by “Business in Vancouver” magazine in the top 100 fastest growing companies and by “BC LifeSciences” magazine as one of the top 13 largest biotech companies in the province of British Columbia (BC), Canada.
-In November 2008, two botanical small-molecule drugs have been approved as oncology prescription drugs for standard cancer treatments by the Ministry of Health of the Republic of Georgia. They have demonstrated higher efficacy than the current conventional chemotherapy. Pegasus will be submitting new drug applications to the U.S. FDA and the EMEA of European Union.
- Pegasus’ unique and innovative NDCR cancer therapy and HS-CSF Stem Cell Stimulotherapy have been applied in over 15,000 cases. If you are a drug-resistant cancer patient in late stage, or have Parkinson's disease, erythematosus or other chronic diseases, Pegasus’ therapies may be your solutions!

Proprietary Technology Platforms:

Preventive Medicine:

Company News：

On May 7, 2010, Pharmacopoeia Committee, Public Health Ministry of the Republic of Uzbekistan has issued a new drug approval for HemoMex™ Dammarane Sapogenins (Ginseng Sapogenins) Injection 2000 mg/100 ml.

On March 22, 2010, the Agency of State Regulation of Medical Activity of the Ministry of Labour, Health and Social Affairs of Georgia has issued a new drug approval for HemoMex S™ Capsule of Dammarane Sapogenins 150 mg.